Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Neoplasms 2 Breast Neoplasms, Male 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunctions, Psychological 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Granulosa cell tumor of the ovary 1 Endometrial Neoplasms 1 Carcinoma, Ductal 1 Breast Carcinoma In Situ 1 Anatomic Stage III Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1 Advanced Breast Cancer 1 Acrocephalosyndactylia 1

Interventions

talimogene laherparepvec 1 exemestane 1 Tamoxifen 1 Surgical Procedures, Operative 1 Specimen Handling 1 Paclitaxel 1 Mastectomy, Segmental 1 Letrozole 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Ductal × exemestane × 90 days × Clear all

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡